Gastro-Esophageal Reflux in Esophageal Atresia Patients Remains a Challenge: Results from a Systematic Review and

Alexander Sterlin1,2, Hanna Garnier3,4, Gabriela Vallejo5,6

  • 1Department of Pediatric Surgery, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany.

Insights

Gastroesophageal reflux disease (GERD) affects over a third of patients after esophageal atresia (EA) repair, often requiring anti-reflux surgery (ARS). Complications from ARS are higher in infants, indicating a need for standardized GERD management in EA patients.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Clinical Research

Background:

  • Esophageal atresia (EA) repair is a complex procedure with ongoing challenges in managing associated gastroesophageal reflux disease (GERD).
  • Current management strategies for GERD post-EA repair lack standardization, leading to controversial treatment approaches.
  • Optimizing GERD management is crucial for improving long-term outcomes in children with a history of EA.

Purpose of the Study:

  • To systematically review and meta-analyze the current management of GERD in children following EA repair.
  • To determine the prevalence of GERD in this population and evaluate the effectiveness of medical and surgical therapies.
  • To identify factors influencing GERD management and outcomes after EA repair.

Main Methods:

  • A systematic review and meta-analysis adhering to PRISMA 2020 guidelines.
  • Comprehensive literature search across MEDLINE, Cochrane Database, and Web of Science for studies on GERD in patients under 18 with prior EA repair.
  • Data extraction focused on GERD incidence, diagnostic methods, medical/surgical interventions, and patient outcomes.

Main Results:

  • The pooled incidence of GERD was 36.7% overall, rising to 58.1% in type A/B EA.
  • While 88% received proton pump inhibitors, 53.8% required further interventions, including anti-reflux surgery (ARS).
  • ARS success was 74.5%, but complications occurred in 28.3%, with higher rates in infants <6 months; redo fundoplication was needed in 14.9%.

Conclusions:

  • GERD is highly prevalent post-EA repair, particularly in types A/B, often necessitating ARS.
  • Medical management alone is frequently insufficient, and ARS in infants carries significant complication risks.
  • Standardized diagnostic criteria and prospective, multicenter registries are essential for optimizing ARS timing and techniques in EA patients.

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
384
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
1.3K
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
577
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
735
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
460